Puma Biotechnology, Inc. (PBYI)

NASDAQ: PBYI · Real-Time Price · USD

10.44

-0.10 (-0.95%)

At close: Oct 30, 2026, 4:00 PM EDT

10.72

+0.28 (2.67%)

After-hours: Oct 30, 2026, 7:59 PM EDT

Puma Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	539	300	150	206	196	124
Market Cap Growth	107.35%	100.26%	-27.32%	5.07%	57.73%	-69.53%
Enterprise Value	450	246	139	233	233	154
Last Close Price	10.44	5.95	3.05	4.33	4.23	3.04

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	20.73	9.64	4.95	9.54	98021.07	-
Forward PE	-	12.55	11.62	10.57	33.92	127.84
PS Ratio	2.33	1.31	0.65	0.87	0.86	0.49
PB Ratio	3.85	2.30	1.63	3.85	9.07	-50.81
P/TBV Ratio	5.28	3.37	3.65	-	-	-
P/FCF Ratio	13.09	7.19	3.85	7.67	-	6.02
P/OCF Ratio	13.10	7.17	3.85	7.63	-	6.02
PEG Ratio	-	25.68	25.68	25.68	25.68	25.68

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.95	1.08	0.61	0.99	1.02	0.61
EV/EBITDA Ratio	11.21	5.20	3.39	5.44	5.74	12.22
EV/EBIT Ratio	14.78	6.61	4.50	7.14	7.58	119.32
EV/FCF Ratio	10.93	5.91	3.59	8.68	-	7.45

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.22	0.80	2.09	5.29	-47.69
Debt / EBITDA Ratio	0.11	0.56	1.66	2.33	2.54	6.78
Debt / FCF Ratio	0.12	0.68	1.91	4.15	-	5.65
Net Debt / Equity Ratio	-0.64	-0.53	-0.29	0.29	1.54	-14.12
Net Debt / EBITDA Ratio	-2.22	-1.45	-0.65	0.36	0.82	2.74
Net Debt / FCF Ratio	-2.16	-1.65	-0.69	0.58	-2.10	1.67
Asset Turnover	1.19	1.06	1.04	1.04	1.02	1.08
Inventory Turnover	5.31	8.17	8.15	10.80	9.47	12.06
Quick Ratio	2.57	1.86	1.38	1.45	1.59	1.05
Current Ratio	2.91	2.00	1.54	1.57	1.73	1.28
Return on Equity (ROE)	21.97%	27.97%	41.60%	57.54%	0.02%	-
Return on Assets (ROA)	9.81%	10.85%	8.72%	9.01%	8.56%	0.34%
Return on Invested Capital (ROIC)	56.55%	51.23%	46.14%	50.21%	0.16%	1.04%
Return on Capital Employed (ROCE)	21.30%	27.60%	26.40%	24.90%	21.20%	1.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.82%	10.38%	20.22%	10.48%	0.00%	-23.43%
FCF Yield	7.64%	13.92%	25.96%	13.04%	-8.07%	16.61%
Buyback Yield / Dilution	-3.62%	-3.16%	-3.26%	-5.83%	-10.56%	-2.69%

SEC Filings: 10-K · 10-Q